wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35002540-05ABEF16-11B2-4302-9562-D5377A71D19A
Q35002540-05ABEF16-11B2-4302-9562-D5377A71D19A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35002540-05ABEF16-11B2-4302-9562-D5377A71D19A
Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose.
P2860
Q35002540-05ABEF16-11B2-4302-9562-D5377A71D19A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35002540-05ABEF16-11B2-4302-9562-D5377A71D19A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d1b107ab797a705d14e8ca26952080001d854c68
P2860
Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors.